Key facts
- Notable investors include Scale Up Partners.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Wizbiosolutions
- ·The full record, as it builds
Funding rounds
No funding rounds for Wizbiosolutions are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Wizbiosolutions
Developer of molecular diagnostic kits intended for the point-of-care and rapid molecular diagnostics market. The company offers molecular diagnostics on-site for highly contagious and lethal pathogens as well as diagnostic kits for respiratory diseases, infectious diseases, veterinary diagnostics and food diagnostics, enabling the healthcare industry to contribute to the improvement of human life and welfare through biotechnology.
- Sector
- Healthcare
- HQ
- Seongnam, South Korea
- Founded
- 2010
- Employees
- 15
- Website
- wizbiosolution.com/
- Ownership
- Privately Held (backing)
Wizbiosolutions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Wizbiosolutions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Wizbiosolutions in its N-PORT filings yet. We sweep new filings monthly.